Abstract
Aims To estimate recent trends in the prevalence of disposable e-cigarette vaping in Great Britain, overall and across ages.
Design The Smoking Toolkit Study, a monthly representative cross-sectional survey. Setting: Great Britain.
Participants 29,976 adults (≥18 years) completed telephone interviews from January 2021 to January 2022.
Measurements Current e-cigarette vapers were asked which type of device they mainly use. We estimated age-specific time trends in the prevalence of current disposable e-cigarette use among vapers and inhaled nicotine use (vaping/smoking) among adults.
Findings From January 2021 to January 2022, there was a 14-fold increase in the percentage of vapers that used disposables, rising from 1.2% to 16.7% (prevalence ratio [PR], 14.4; 95%CI, 6.6-49.0). Growth in disposable e-cigarette vaping was most pronounced in younger adults (interaction p-value, .0.007): for example, the percentage of 18-year-old vapers using of disposables rose from 0.89% to 56.7% (PR, 64; 95%CI, 15-5790) while it rose from 1.3% to 6.2% (PR, 4.7; 95%CI, 1.7-144) among 45-year-old vapers. However, the overall percentage people currently using any inhaled nicotine, vaped or smoked, remained stable over time both among all adults (20.1% vs. 20.6%; PR, 1.03; 95%CI, 0.88-1.20) and among 18-year-olds (29.6% vs. 29.6%; PR, 1.00; 95%CI, 0.79-1.26).
Conclusions Use of disposable e-cigarettes in Great Britain grew rapidly between 2021 and 2022, especially among younger adults, but the overall prevalence of inhaled nicotine use — smoked or vaped — was stable over time. Most young adult vapers in Great Britain now use disposable products.
Competing Interest Statement
HTB, LK, MD, and SJ declare no conflicts of interest. JB has received unrestricted research funding to study smoking cessation from manufacturers of smoking cessation medications (Pfizer and Johnson & Johnson).
Funding Statement
Cancer Research UK provides funding for the Smoking Toolkit Study in England and salary support for SJ (PRCRPG-Nov21/100002). The UK Prevention Research Partnership (MR/S037519/1) funds the Smoking Toolkit Study in Scotland and Wales and provides salary support for LK. The UK Prevention Research Partnership is funded by the British Heart Foundation, Cancer Research UK, Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Health and Social Care Research and Development Division (Welsh Government), Medical Research Council, National Institute for Health Research, Natural Environment Research Council, Public Health Agency (Northern Ireland), The Health Foundation and Wellcome. HTB's studentship is funded by the Office for Health Improvement and Disparities, previously Public Health England (558585/180737).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University College London Ethics Committee provided approval for the study (0498/001), and participants gave oral informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
